Viking Global Investors’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-703,424
Closed -$25.3M 123
2020
Q4
$25.3M Sell
703,424
-139,576
-17% -$4.89M 0.07% 87
2020
Q3
$23.7M Sell
843,000
-206,000
-20% -$7.29M 0.09% 81
2020
Q2
$45.4M Sell
1,049,000
-201,000
-16% -$9.1M 0.2% 63
2020
Q1
$47.5M Sell
1,250,000
-237,329
-16% -$9.25M 0.25% 55
2019
Q4
$40.4M Buy
+1,487,329
New +$37.5M 0.19% 57

Viking Global Investors's VIE Position: Q1 2021 in Review

Viking Global Investors sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 703,424 shares — an estimated $25.3M sold.

Viking Global Investors first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $47.5M in Q1 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

  • Viking Global Investors reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Viking Global Investors sold 703,424 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $25.3M.
  • Viking Global Investors first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
  • Viking Global Investors's Viela Bio, Inc. Common Stock position peaked at $47.5M in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Viking Global Investors's 13F filing for Q1 2021, filed 17 May 2021.